USA TODAY | October 23, 2023
“What makes these cases interesting and important is not the fact that the FDA is being challenged. That has happened before,” said Lawrence Gostin, who directs the O’Neill Institute for National and Global Health Law at Georgetown University. “These cases, however, go to the heart of the FDA’s scientific determinations.”